Seminar Series
CRINA Connects
Wednesdays at 12 p.m.
The CRINA Connects Seminar Series is designed to showcase the innovative work being done by cancer researchers at the ¾ÅÐãÖ±²¥ and provides an opportunity for CRINA members to connect with and learn from other researchers around the world. The Seminars are held each Wednesday, at 12 noon (MT).
If you are interested in attending a seminar, please contact crina@ualberta.ca.
2024-2025 CRINA Connects Seminar Series
September 4, 2024
Dr. Hanne Ostergaard, "CRINA peer review and grant support"
September 11, 2024
Dr. Jason Northey, ""Mechanoregulation of hormone-dependent cell plasticity in breast cancer progression""
September 18, 2024
Dr. Dean Chamberlain, "3D microtissue models of breast and ovarian cancer" * In-Person (Bernard Snell Hall)
September 25, 2024
Dr. Edan Foley, "Oh my NOD! Immune regulation of intestinal homeostasis"
ACF Game Changer Grant Seminars x CRINA Connects
October 3, 2024
Dr. Roseline Godbout, “Investigating the link between metabolism and prostate cancer progression”* In-Person (Michael J. Hutchinson, 2279 Cross Cancer Institute)
October 10, 2024
Dr. Ing Swie Goping, "A patient-derived organoid platform for next-level breast cancer research” * In-Person (Zane Feldman Auditorium, 2286 Cross Cancer Institute)
October 17, 2024
Dr. Vickie Baracos, "Cancer cachexia: breaking the spiral of wasting and treatment toxicity” * In-Person (Zane Feldman Auditorium, 2286 Cross Cancer Institute)
October 24, 2024
Dr. Kristi Baker, “Immune resistance mechanisms in late-stage genetically
unstable cancers” * In-Person (Zane Feldman Auditorium, 2286 Cross Cancer Institute)
CRINA Connects Resumes
October 30, 2024
Dr. Nicolas Jacquelot, "Harnessing type 2 innate lymphoid cells in cancer" * In-Person (ECHA L1-430)
November 6, 2024
Danielle Simonot, "Presenting the ¾ÅÐãÖ±²¥ Cancer Research Biobank (ACRB): Providing Samples and Data to ¾ÅÐãÖ±²¥ Researchers Since (at least) 2002"
November 20, 2024
Dr. Reza Mirzaei, "Understanding the Tumor Microenvironment to Improve Immunotherapy in Cold Tumors"
November 27, 2024
Dr. John Lewis, "Development of highly selective genetic medicines as cancer therapeutics"
December 4, 2024
No seminar this week
December 11, 2024
Dr. Gopinath Sutendra, "Can tissue-specific differences in redox status provide therapeutic selectivity in cardio-oncology?"
December 18, 2024
Dr. Shane Harding, "Micronuclei as a window to the DNA damage response" *In-Person (ECHA 2-190)
January 8, 2025
Dr. Andrew Mason ""Human betaretrovirus, autoimmunity and breast cancer"
January 15, 2025
No seminar this week
January 22, 2025
Dr. Richard Fahlman, "Emerging Technologies and Applications in Proteomics for Mechanistic and Clinical Studies"
January 29, 2025
Dr. Jack Tuszyński, "Investigations of the effects of electric and electromagnetic fields on cancer cells and the cytoskeleton"
February 5, 2025
Dr. Lynne-Marie Postovit, "Mechanistic Underpinnings of Cancer Cell Plasticity"
February 12, 2025
Dr. Lisa Willis, "Polysialylation is a general feature of immune activation"
February 26, 2025
Dr. Catherine Field, "Results of the primary and secondary outcomes of the DHA-Win Trial in women with breast cancer"
March 5, 2025
Dr. Ivan Bogeski, "Calcium and Redox Signals at Cellular Interfaces: Implications for Cancer and Immunity: *In-Person (ECHA 1-490)
March 12, 2025
Dr. Ismail Ismail, "MAEA: A New Piece in the DNA Repair Puzzle" *In-Person (ECHA 2-420)
March 19, 2025
Dr. Arno Siraki, "Drug-Induced Free Radical Formation in Neutrophils and Promyelocytic Leukemia Cells – What is the Common Link?"
March 26, 2025
Dr. Russ Greiner, "Working with Medical Colleagues to Produce Effective Prediction Systems"
April 2, 2025
Dr. Konstantin Stoletov, "Adrenomedullin 2 as a Driver of Cancer Cell Intravasation: Intravital Discovery"
April 9, 2025
Dr. Costin Antonescu "Receptor signaling at the nanoscale: how organization of signals at the plasma membrane regulate signaling specificity and outcome"
April 16, 2025
Ghada Aborkees, "Title: Leukemic Lymphoblasts Express Hemostatic System Factors: Mechanisms and Biomarkers for VTE Risk"
April 23, 2025
No seminar this week
April 30, 2025
Dr. Jenilee Woodfield, "Targeting ubiquitin-specific protease 14 (USP14): An innovative biomarker for molecular imaging of multiple myeloma" & Dr. Connie Le, "Combining Radiotherapy and Immunotherapy to treat Hepatocellular Carcinoma"
May 7, 2025
Sharon Basaraba, “Long Story Short: How to Write a Lay Summary”
May 14, 2025
No seminar this week
May 21, 2025
Dr. Simon Gravel, "Tracking cancer risk in (very) large genealogies"
May 28, 2025
Dr. David Wishart, "How Metabolomics Facilitates a Multi-omics View on Cancer"